Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Pibrentasvir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 43,655Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enanta Pharma Announces Sale of a Portion of Global Royalties on MAVYRET
    Enanta Pharma Announces Sale of a Portion of Global Royalties on MAVYRET

    25 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230424005919/en

    BUSINESSWIRE
    25 Apr 2023
    Share Share
    Enanta Pharmaceuticals Doses First Subject in a Phase 1 Study of EDP-323
    Enanta Pharmaceuticals Doses First Subject in a Phase 1 Study of EDP-323

    17 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221017005153/en

    BUSINESSWIRE
    17 Oct 2022
    Share Share
    EU Marketing Authorisation change for Maviret
    EU Marketing Authorisation change for Maviret

    09 Mar 2020

    // Anna Smith PHARMA TIMES

    http://www.pharmatimes.com/news/eu_marketing_authorisation_change_for_maviret_1328393

    Anna Smith PHARMA TIMES
    09 Mar 2020
    Share Share
    AbbVie gets positive CHMP opinion for Maviret to shorten treatment
    AbbVie gets positive CHMP opinion for Maviret to shorten treatment

    03 Feb 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=120946&sid=2

    PHARMABIZ
    03 Feb 2020
    Share Share
    AbbVie Receives Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir)
    AbbVie Receives Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir)

    31 Jan 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbvie-receives-positive-chmp-opinion-for-maviret-glecaprevirpibrentasvir-to-shorten-treatment-duration-to-eight-weeks-in-genotype-3-treatment-naive-patients-with-chronic-hepatitis-c-and-compensated-cirrhosis-300996801.html

    PR NEWSWIRE
    31 Jan 2020
    Share Share
    AbbVie’s HCV treatment receives first for shorter treatment cycle
    AbbVie’s HCV treatment receives first for shorter treatment cycle

    30 Sep 2019

    // B. Hargreaves IN-PHARMATECHNOLOGIST

    https://www.in-pharmatechnologist.com/Article/2019/09/30/AbbVie-receives-approval-HCV-treatment

    B. Hargreaves IN-PHARMATECHNOLOGIST
    30 Sep 2019
    Share Share